A content analysis of direct-to-consumer (dtc) prescription drug web sites

Journal of Advertising

Volumn 32, Issue 4, 2003, Pages 43-56

  Macias, Wendy ^a   Lewis, Liza Stavchansky ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b Spectra Marketing   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2442463417     PISSN: 00913367     EISSN: None     Source Type: Journal    
DOI: 10.1080/00913367.2003.10639147     Document Type: Article

References (54)

1. Alperstein, Neil, and Mark Peyrot (1993), “Consumer Awareness of Prescription Drug Advertising, ” Journal of Advertising Research (July/August), 50-56.
2. American Marketing Association (AMA) (1997), Policy Compendium, 227-228.
3. Bell, Robert A., Richard L. Kravitz, and Michael S. Wilkes (2000), “Direct-to-Consumer Prescription Drug Advertising, 1989-1998: A Content Analysis of Conditions, Targets, Inducements, and Appeals, ” Journal of Family Practice, 49 (4), 329-335.
4. Bell, Robert A, Michael S. Wilkes, and Richard L. Kravitz (2000), ‘The Educational Value ofConsumer-Targeted Prescription Drug Print Advertising, ” Journal of Family Practice, 49 (12), 1092-1098.
5. Burton, Philip Ward (1990), Advertising Copywriting, 6th ed., Lincolnwood, IL: NTC Business Books.
6. Calfee, John E. (2002), “Public Policy Issues in Direct-to-Con-sumer Advertising of Prescription Drugs, ” Journal of Public Policy and Marketing, 21 (2), 174-193.
7. Chan-Olmsted, Sylvia, and Jung Suk Park (2000), “From On-Air to Online World: Examining the Content and Structures of Broadcast TV Stations’ Web Sites, ” Journalism and Mass Communication Quarterly, 77 (2), 321-339.
8. Cohen, Eric P. (1998), “Sounding Board: Direct-to-Consumer Public Advertisement of Prescription Drugs, ” New England Journal of Medicine, 373-375.
9. Coney, Sandra (2002), “Direct-to-Consumer Advertising of Prescription Pharmaceuticals: A Consumer Perspective from New Zealand, ” Journal of Public Policy and Marketing, 21 (2), 213-223.
10. Coulter, Angela, Vikki Entwhistle, and David Gilbert (1998), Informing Patients: An Assessment of the Quality of Patient Information Materials, London: King’s Fund.
11. Coyle, James R., and Esther Thorson (2001), “The Effects of Progressive Levels of Interactivity and Vividness in Web Marketing Sites, ” Journal of Advertising, 30 (3), 65-77.
12. Federal Trade Commission (FTC) (1996), “Before the Department of Health and Human Services Food and Drug Administration in the Matter of Direct-to-Consumer Promotion” (January 11, Public Hearing Docket no. 95N-0227), available at www.ftc.gov (accessed June 3, 2003).
13. Fetto, John (2002), “Drugged Out, ” American Demographics, 24 (5), 11.
14. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER) (1997), “Draft Guidance for Industry: Consumer-Directed Broadcast Advertisements, ” Federal Register, 62, no. 155 (August 12, Docket no. 97D-0320), 43171-43173.
15. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER) (1999), “Guidance for Industry: Consumer-Directed Broadcast Advertisements, ” Federal Register, 64, no. 152 (August 9, Docket no. 97D-0302), 43197-43198.
16. Frazer, Charles, and Sally J. McMillan (1999), “Sophistication on the World Wide Web: Evaluating Structure, Function, and Commercial Goals of Web Sites, ” in Advertising and the World Wide Web, David W. Schumann and Esther Thorson, eds., Mahwah, NJ: Lawrence Erlbaum, 119-134.
17. Friedler, Edward (1997), “The Evolving Doctor-Patient to Provider-Consumer Relationship, ” Journal of Family Practice, 45 (December), 485.
18. Green, K. (1998), “Marketing Health-Care Products on the Internet: A Proposal for Updated Federal Regulations, ” American Journal of Law and Medicine, 24 (2/3), 365-386.
19. Haubl, Gerald, and Valerie Trifts (2000), “Consumer Decision Making in Online Shopping Environments: The Effects of Interactive Decision Aids, ” Marketing Science, 19 (1), 4-21.
20. The Henry J. Kaiser Family Foundation (2001), “Understanding the Effects of Direct-to-Consumer Prescription Drug Advertising” (November).
21. Holsti, Ole R. (1969), Content Analysis for the Social Sciences and Humanities, Reading, MA: Addison-Wesley.
22. Humphreys, Andrew (2000), “Out of Site: The Top 10 HealthCare Websites Are Fast, Informative, Artistic, Innovative, Creative, and Easy to Use, ” MedAdNews, 19 (12), 5, 10-12.
23. Kelley, Gordon (2002), “Brand Advertising on a Roll, ” Pharmaceutical Executive, 22 (6), 118.
24. Krippendorff, Klaus (1980), Content Analysis: An Introduction to Its Methodology, Beverly Hills, CA: Sage.
25. Law, Jacky (1998), “Assessing the Impact of Direct-to-Consumer Advertising, ” Scrip Magazine (November), 21-22.
26. Li, Hairong, and Janice L. Bukovac (1999), “Cognitive Impact of Banner Ad Characteristics: An Experimental Study, ” Journalism and Mass Communication Quarterly, 76 (2), 341-353.
27. McCarthy, Robert (1998), “Managed Care Matters-Major Managed Pharmacy Issues: Cost, Cost … Copays?” Drug Benefit Trends, 10 (9), 22, available at www.medscape.com (accessed June 3, 2003).
28. Macias, Wendy (2003), “A Beginning Look at the Effects of Interactivity, Product Involvement and Web Experience on Comprehension: Brand Web Sites as Interactive Advertising, ” Journal of Current Issues and Research in Advertising, 25 (2), 31-44.
29. McMillan, Sally J. (2000), “The Microscope and the Moving Target: The Challenge of Applying Content Analysis to the World Wide Web, ” Journalism and Mass Communication Quarterly, 77 (1), 80-98.
30. McMillan, Sally J., and Jang-Sun Hwang (2002), “Measures of Perceived Interactivity: An Exploration of the Role of Direction of Communication, User Control, and Time in Shaping Perceptions of Interactivity, ” Journal of Advertising, 31 (3), 41-54.
31. Maddox, Lynda M. (1999), “The Use of Pharmaceutical Web Sites for Prescription Drug Information and Product Requests, ” Journal of Product and Brand Management, 8 (6), 488-501.
32. Maddox, Lynda M., Darshan Mehta, and Hugh G. Daubek (1997), “The Role and Effect of Web Addresses in Advertising, ” Journal of Advertising Research (March/April), 47-59.
33. Matthews, Merrill (2001), “Advertising Drugs is Good for Patients: Lowers Costs to Consumers, ” Consumers’ Research (August), 15-20.
34. Nader, Ralph (1999), “Is DTC in the Best Interest of Public Health?” in IBC’s 1999 Inaugural DTC Marketing Congress, Sothborough, MA: IBC.
35. Neff, Jack (2002), “Drugmakers Up Use of Celebs in Ads, Risking an Overdose or Critics’ Ire, ” Advertising Age (May 24, Special Report: DTC Marketing), S-4.
36. Novak, Thomas P, Donna L. Hoffman, and Yiu-Fai Yung (2000), “Measuring the Customer Experience in Online Environments: A Structural Modeling Approach, ” Marketing Science, 19 (1), 22-42.
37. Parker, Betty J., and Linda M. Delene (1998), “Direct-to-Con-sumer Prescription Drug Advertising: Content Analysis and Public Policy Implications, ” Journal of Pharmaceutical Marketing and Management, 12 (4), 27-42.
38. Parker, Betty J., and Linda M. Delene (1999), “The Marketing of Direct-to-Consumer Prescription Drugs: An Examination of Advertising Content, ” Journal of Promotion Management, 5 (1), 37-55.
39. People’s Medical Society (1996), “Drug Ads to Consumers on the Rise, ” People’s Medical Society Newsletter, 15 (April), 1.
40. Peterson, Carolyn (1998), “I Read It over Breakfast: Print Proves Its Appeal with Some All-Ink DTC Campaigns, ” Pharmaceutical Executive: DTC Times (September 6-10).
41. Prescription Access Litigation (2002), “Claritin” (September 15), available at www.prescriptionacesslitigation.org/clartin.htm (accessed June 3, 2003).
42. Realto, Vern (1998a), “Prescription Meds Meet the Web, ” Pharmaceutical Executive, 18 (11), DTC6-DTC16.
43. Realto, Vern (1998b), “1998 Top 10: Best of the Best, ” Pharmaceutical Executive, 18 (12), S6-S11.
44. Resnik, Alan, and Bruce L. Stern (1977), “An Analysis of Information Content in Television Advertising, ” Journal of Marketing, 41, 50-53.
45. Riffe, Daniel, Stephen Lacy, and Frederick Fico (1998), Analyzing Media Messages: Using Quantitative Content Analysis in Research, Mahwah, NJ: Lawrence Erlbaum.
46. Roth, Martin S. (1996), “Patterns in Direct-to-Consumer Prescription Drug Print Advertising and Their Public Policy and Marketing Implications, ” Journal of Public Policy and Marketing, 15 (Spring), 63.
47. Russell, J. Thomas, and W. Ron Lane (2002), Kleppner’s Advertising Procedure, 15 th ed., Upper Saddle River, NJ: Prentice Hall.
48. Scussa, Frank (2001), “Getting Noticed: The Future of Consumer Promotion Is Being Challenged by Government Agencies and the Public, ” MedAdNews, 20 (6), 1, 40-45.
49. Twibell, Dan, and Mark Anzalone (2001), “DTC on the Web- Fad or Fundamental?” DTC Perspectives (May/June), 28-29.
50. Von Knoop, Carina, Deborah Lovich, Martin B. Silverstein, and Michael Tutty (The Boston Consulting Group) (2003), “Vital Signs: E-Health in the United States” (January 3), available at www.bcg.com/publications/files/Vital_ Signs_Rpt_Jan03.pdf (accessed June 3, 2003).
51. Weare, Christopher, and Wan-Ying Lin (2000), “Content Analysis of the World Wide Web: Opportunities and Challenges, ” Social Science Computer Review, 18 (3), 272-292.
52. Wilkes, Michael S., Robert A. Bell, and Richard L. Kravitz (2000), “Direct-to-Consumer Prescription Drug Advertising: Trends, Impact, and Implications, ” Health Affair, 19 (2), 110-128.
53. Wogalter, Michael S., Tonya L. Smith-Jackson, Brian J. Mills, and Corrina S. Paine (2002), “The Effects of Print Format in Direct-to-Consumer Prescription Drug Advertisements on Risk Knowledge and Preference, ” Drug Information Journal, 36, 693-705.
54. Woloshin, Steven, Lisa M. Schwartz, Jennifer Tremmel, and H. Gilbert Welch (2001), “Direct-to-Consumer Advertisements for Prescription Drugs: What Are Americans Being Sold?” The Lancet, 358 (October), 1141-1146.